Zobrazeno 1 - 10
of 590
pro vyhledávání: '"Skvortsova VI"'
Autor:
Rabdano SO; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia. Electronic address: sevastyan@rabdano.ru., Ruzanova EA; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Vertyachikh AE; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Teplykh VA; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Emelyanova AB; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Rudakov GO; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Arakelov SA; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Pletyukhina IV; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Saveliev NS; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Lukovenko AA; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Fakhretdinova LN; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Safi AS; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Zhirenkina EN; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Polyakova IN; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Belozerova NS; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Klykov VV; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Savelieva AP; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Ekimov AA; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Pokachalov KV; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), Saint Petersburg, Russia., Merkulov VA; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia; Centre for Evaluation and Control of Finished Pharmaceutical Products, Federal State Budgetary Institution 'Scientific Centre for Expert Evaluation of Medicinal Products' of the Ministry of Health of the Russian Federation, Moscow, Russia., Yudin SM; Centre for Strategic Planning of FMBA of Russia Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Kruchko DS; Federal Medical-Biological Agency of Russia, Moscow, Russia., Berzin IA; Federal Medical-Biological Agency of Russia, Moscow, Russia., Skvortsova VI; Federal Medical-Biological Agency of Russia, Moscow, Russia.
Publikováno v:
The Journal of infection [J Infect] 2024 Nov; Vol. 89 (5), pp. 106288. Date of Electronic Publication: 2024 Sep 26.
Autor:
Grebnev PA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Meshkov IO; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Ershov PV; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Makhotenko AV; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Azarian VB; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Erokhina MV; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Galeta AA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Zakubanskiy AV; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Shingalieva OS; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Tregubova AV; Federal State Budgetary Institution 'National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov', Ministry of Healthcare of The Russian Federation, Oparina Street, Bld. 4, 117997 Moscow, Russia., Asaturova AV; Federal State Budgetary Institution 'National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov', Ministry of Healthcare of The Russian Federation, Oparina Street, Bld. 4, 117997 Moscow, Russia., Yudin VS; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Yudin SM; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Makarov VV; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Keskinov AA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Makarova AS; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Snigir EA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Bld. 1, Pogodinskaya Street, 10, 119121 Moscow, Russia., Skvortsova VI; Federal Medical Biological Agency (FMBA of Russia), Volokolamskoye Shosse, 30, 123182 Moscow, Russia.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Sep 24; Vol. 16 (19). Date of Electronic Publication: 2024 Sep 24.
Autor:
Britanova OV; Pirogov Russian National Research Medical University, Moscow, Russia.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia., Lupyr KR; Pirogov Russian National Research Medical University, Moscow, Russia.; Skolkovo Institute of Science and Technology, Moscow, Russia., Staroverov DB; Pirogov Russian National Research Medical University, Moscow, Russia.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia., Shagina IA; Pirogov Russian National Research Medical University, Moscow, Russia.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia., Aleksandrov AA; BIOCAD, St. Petersburg, Russia., Ustyugov YY; BIOCAD, St. Petersburg, Russia., Somov DV; Pirogov Russian National Research Medical University, Moscow, Russia., Klimenko A; Pirogov Russian National Research Medical University, Moscow, Russia., Shostak NA; Pirogov Russian National Research Medical University, Moscow, Russia., Zvyagin IV; Pirogov Russian National Research Medical University, Moscow, Russia.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia., Stepanov AV; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia., Merzlyak EM; Pirogov Russian National Research Medical University, Moscow, Russia.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia., Davydov AN; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; MiLaboratories Inc., Sunnyvale, CA, USA., Izraelson M; MiLaboratories Inc., Sunnyvale, CA, USA., Egorov ES; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany., Bogdanova EA; Pirogov Russian National Research Medical University, Moscow, Russia., Vladimirova AK; BIOCAD, St. Petersburg, Russia., Iakovlev PA; BIOCAD, St. Petersburg, Russia., Fedorenko DA; Department of Hematology and Chemotherapy, Pirogov National Medical and Surgical Center, Moscow, Russia., Ivanov RA; BIOCAD, St. Petersburg, Russia., Skvortsova VI; Pirogov Russian National Research Medical University, Moscow, Russia.; Federal Medical Biological Agency, Moscow, Russia., Lukyanov S; Pirogov Russian National Research Medical University, Moscow, Russia.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia., Chudakov DM; Pirogov Russian National Research Medical University, Moscow, Russia. chudakovdm@gmail.com.; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia. chudakovdm@gmail.com.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic. chudakovdm@gmail.com.; Abu Dhabi Stem Cell Center, Al Muntazah, United Arab Emirates. chudakovdm@gmail.com.
Publikováno v:
Nature medicine [Nat Med] 2023 Nov; Vol. 29 (11), pp. 2731-2736. Date of Electronic Publication: 2023 Oct 23.
Recent progress in understanding the pathological changes in the nervous system and in certain other body systems (e.g., immune system) that lead to the development and progression of amyotrophic lateral sclerosis (ALS) revealed a number of molecular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::038b5de26e2bfb3754c8979713911d02
https://orca.cardiff.ac.uk/id/eprint/134969/3/In+a+search+for+efficient+treatment+for+amyotrophic+lateral+sclerosis+-+old+drugs+for+new+approaches.pdf
https://orca.cardiff.ac.uk/id/eprint/134969/3/In+a+search+for+efficient+treatment+for+amyotrophic+lateral+sclerosis+-+old+drugs+for+new+approaches.pdf
Autor:
Vladislav N Karkischenko, Maxim S Nesterov, Oxana V Alimkina, Melik T Gasanov, Igor A Pomytkin, Nataliya V Petrova, Skvortsova Vi, Yuriy V Fokin
Publikováno v:
Journal of Immunology Research
Journal of Immunology Research, Vol 2021 (2021)
Journal of Immunology Research, Vol 2021 (2021)
COVID-19 is a respiratory infection caused by the SARS-CoV-2 virus that can rapidly escalate to life-threatening pneumonia and acute respiratory distress syndrome (ARDS). Recently, extracellular high mobility group box 1 (HMGB1) has been identified a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff7d05db5b0e527011496645f783efcd
http://europepmc.org/articles/PMC8490075
http://europepmc.org/articles/PMC8490075
Autor:
Matsvay A; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Klink GV; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia., Safina KR; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia., Nabieva E; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia., Garushyants SK; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia., Biba D; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia., Bazykin GA; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia.; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia., Mikhaylov IM; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Say AV; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Zakamornaya AI; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Khakhina AO; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Lisitsa TS; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Ayginin AA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Abramov IS; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Bogdan SA; Chief Federal State Budgetary Healthcare Institution 'Centre of Hygiene and Epidemiology' of the Federal Medical Biological Agency, Moscow, Russia., Kolbutova KB; Chief Federal State Budgetary Healthcare Institution 'Centre of Hygiene and Epidemiology' of the Federal Medical Biological Agency, Moscow, Russia., Oleynikova DU; Chief Federal State Budgetary Healthcare Institution 'Centre of Hygiene and Epidemiology' of the Federal Medical Biological Agency, Moscow, Russia., Avdeenko TF; Chief Federal State Budgetary Healthcare Institution 'Centre of Hygiene and Epidemiology' of the Federal Medical Biological Agency, Moscow, Russia., Shipulin GA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Yudin SM; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia., Skvortsova VI; Federal Medical Biological Agency, Moscow, Russia.
Publikováno v:
PloS one [PLoS One] 2023 May 16; Vol. 18 (5), pp. e0285664. Date of Electronic Publication: 2023 May 16 (Print Publication: 2023).
Autor:
Rabdano SO; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), St. Petersburg 198320, Russia., Ruzanova EA; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), St. Petersburg 198320, Russia., Pletyukhina IV; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), St. Petersburg 198320, Russia., Saveliev NS; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), St. Petersburg 198320, Russia., Kryshen KL; RMC 'Home of Pharmacy' JSC, Kuzmolovsky 188663, Russia., Katelnikova AE; RMC 'Home of Pharmacy' JSC, Kuzmolovsky 188663, Russia., Beltyukov PP; Scientific Research Institute of Hygiene, Occupational Pathology and Human Ecology of the Federal Medical-Biological Agency of Russia (SRIHOPHE), Kuzmolovsky 188663, Russia., Fakhretdinova LN; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), St. Petersburg 198320, Russia., Safi AS; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), St. Petersburg 198320, Russia., Rudakov GO; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), St. Petersburg 198320, Russia., Arakelov SA; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), St. Petersburg 198320, Russia., Andreev IV; National Research Center Institute of Immunology (NRCII), Federal Medical-Biological Agency of Russia, Moscow 115522, Russia., Kofiadi IA; National Research Center Institute of Immunology (NRCII), Federal Medical-Biological Agency of Russia, Moscow 115522, Russia.; Department of Immunology, N.I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow 117997, Russia., Khaitov MR; National Research Center Institute of Immunology (NRCII), Federal Medical-Biological Agency of Russia, Moscow 115522, Russia.; Department of Immunology, N.I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow 117997, Russia., Valenta R; National Research Center Institute of Immunology (NRCII), Federal Medical-Biological Agency of Russia, Moscow 115522, Russia.; Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.; Laboratory of Immunopathology, Department of Clinical Immunology and Allergology, I.M. Sechenov First Moscow State Medical University, Moscow 119435, Russia.; Karl Landsteiner University of Health Sciences, 3500 Krems, Austria., Kryuchko DS; Federal Medical-Biological Agency of Russia, Moscow 125310, Russia., Berzin IA; Federal Medical-Biological Agency of Russia, Moscow 125310, Russia., Belozerova NS; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), St. Petersburg 198320, Russia., Evtushenko AE; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), St. Petersburg 198320, Russia., Truhin VP; Saint Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical-Biological Agency of Russia (SPbSRIVS), St. Petersburg 198320, Russia., Skvortsova VI; Federal Medical-Biological Agency of Russia, Moscow 125310, Russia.
Publikováno v:
Vaccines [Vaccines (Basel)] 2023 Apr 20; Vol. 11 (4). Date of Electronic Publication: 2023 Apr 20.
Autor:
Akhmerova YN; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Shpakova TA; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Grammatikati KS; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Mitrofanov SI; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Kazakova PG; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Mkrtchian AA; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Zemsky PU; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Pilipenko MN; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Feliz NV; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Frolova LV; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Frolovskaya AA; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Yudin VS; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Keskinov AA; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Kraevoy SA; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Yudin SM; Federal State Budgetary Institution 'Center for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency (Center for Strategic Planning of FMBA of Russia), Moscow, 119121 Russian Federation., Skvortsova VI; Federal Medical Biological Agency (FMBA of Russia), Moscow, 123182 Russian Federation.
Publikováno v:
Acta naturae [Acta Naturae] 2023 Jan-Mar; Vol. 15 (1), pp. 31-41.
In a search for efficient treatment for amyotrophic lateral sclerosis: Old drugs for new approaches.
Autor:
Kukharsky MS; Faculty of Medical Biology, Pirogov Russian National Research Medical University, Moscow, Russian Federation.; Institute of Physiologically Active Compounds, Russian Academy of Sciences, Moscow Region, Russian Federation., Skvortsova VI; Faculty of Medical Biology, Pirogov Russian National Research Medical University, Moscow, Russian Federation., Bachurin SO; Institute of Physiologically Active Compounds, Russian Academy of Sciences, Moscow Region, Russian Federation., Buchman VL; Institute of Physiologically Active Compounds, Russian Academy of Sciences, Moscow Region, Russian Federation.; School of Biosciences, Cardiff University, Cardiff, United Kingdom.
Publikováno v:
Medicinal research reviews [Med Res Rev] 2021 Sep; Vol. 41 (5), pp. 2804-2822. Date of Electronic Publication: 2020 Aug 20.
Autor:
Shaymardanov AM; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Antonova OA; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Sokol AD; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Deinichenko KA; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Kazakova PG; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Milovanov MM; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Zakubansky AV; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Akinshina AI; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Tsypkina AV; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Romanova SV; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Muhin VE; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Mitrofanov SI; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Yudin VS; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Yudin SM; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Makhotenko AV; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Keskinov AA; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Kraevoy SA; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Snigir EA; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Svetlichnyy DV; Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical-Biological Agency, 10 Bld., 1 Pogodinskaya Str., Moscow 119121, Russia., Skvortsova VI; The Federal Medical Biological Agency (FMBA of Russia), 30 Volokolamskoe sh., Moscow 125310, Russia.
Publikováno v:
Cells [Cells] 2022 Sep 21; Vol. 11 (19). Date of Electronic Publication: 2022 Sep 21.